#PxWire
“This issue really does highlight why the world should be excited, but why we also have to be worried…” - Mitchell Warren reflecting on the new issue of #PxWire

🔗 www.linkedin.com/feed/update/...

Watch below and explore the latest PxWire, avac.org/pxwire/

#HIV #PrEP #HIVprevention #AIDS2026
#pxwire #aids2026 #aids2026 #prep #lenacapavir #cabotegravir #alimatravir | AVAC
In the latest issue of #PxWire, AVAC’s Mitchell Warren reflects on some of the most important developments coming out of #AIDS2026 and the tension between a pipeline that continues to advance and a gl...
www.linkedin.com
September 9, 2026 at 6:47 PM
Our new issue of #PxWire cover's Merck/MSD’s decision to license #alimatravir to 7 generic manufacturers before efficacy results, setting a benchmark for access.

But gaps remain, including the exclusion of Brazil & other countries from the license.

Read more: avac.org/resource/rep...

#PrEP #HIV
August 27, 2026 at 2:49 PM
The 2.5 million new PrEP users documented by PEPFAR in 2024 could now lose access to PEPFAR- supported PrEP services, despite the limited and inconsistently implemented waiver from the US Department of State. Learn more in AVAC's latest PxWire ➡️ avac.org/resource/rep...
@hivpxresearch.bsky.social
May 7, 2025 at 7:59 PM
The latest PxWire from @hivpxresearch.bsky.social highlights major setbacks in the #HIV response: "Policies by the new US Presidential administration have derailed the entire field, potentially setting back the HIV response by years, if not decades." ➡️ ow.ly/JEfl50VcHCu
PxWire Volume 15, Issue No. 1
In this special edition of Px Wire, AVAC is going beyond a quarterly update of biomedical HIV prevention. In this issue, we look at how the new US Administration’s attack on global health can be expec...
ow.ly
March 7, 2025 at 3:35 PM
AVAC -- New PxWire: PEPFAR funding cuts + generic licensing + latest developments for long-acting treatment and bNAbs

bit.ly/4y0pPn1 @avac.org
August 26, 2026 at 11:12 AM
AVAC: New PxWire: Declining PrEP initiations + updated LEN commitments + long-acting HIV treatment pipeline

bit.ly/4wavJSi @avac.org
lenacapavir etc
May 6, 2026 at 12:18 PM
AVAC: PxWire Volume 16, Issue 1

bit.ly/4qem60F

@avac.org
January 31, 2026 at 6:10 PM
AVAC: PxWire is out! See where LEN arrives first + updates on trials for 1x month PrEP pill and more

bit.ly/475Z8Tq

@avac.org
October 23, 2025 at 12:26 PM
Great piece by @jirairratevosian.bsky.social and mike Reid ⬇️

Also out today is AVAC's latest issue of PxWire, which breaks down the latest PEPFAR data—showing declines in PrEP initiations and what’s still missing.

avac.org/resource/rep...
May 6, 2026 at 4:55 PM
New PxWire is out 📊

AVAC breaks down the latest #PEPFAR data—showing declines in #PrEP initiations and what’s still missing—amid ongoing fallout from funding cuts. Plus: what new #LEN commitments really mean, and a look at the long-acting #HIV pipeline.

Read more: avac.org/resource/rep...
PxWire Volume 16, Issue 2
This issue showcases AVAC’s analysis of the recent PEPFAR data release, assessing how uptake of prevention programs—particularly PrEP initiations—have declined over the last year. As the field grapple...
avac.org
May 6, 2026 at 3:02 PM
Momentum continues in the #HIV R&D pipeline— with two early-phase #Vaccine trials, a late-phase monthly #PrEP pill, and advancing #HIVcure research. Stay current on the science shaping prevention and cure in #PxWire:
buff.ly
February 5, 2026 at 3:30 PM
The latest issue of #PxWire showcases how access to #LEN for PrEP is accelerating—and why its delivery is moving faster than any #PrEP product before it.
buff.ly
February 4, 2026 at 4:31 PM
Hot off the presses! The #PEPFAR stopwork order resulted in major declines in #PrEPAccess. Our latest issue of #PxWire shows the impact, country by country, with significant declines to life-saving #PrEP. #DeadlyPause buff.ly/tC66sCu
February 3, 2026 at 1:35 PM
Momentum continues in the #HIV R&D pipeline— with two early-phase #Vaccine trials, a late-phase monthly #PrEP pill, and advancing #HIVcure research. Stay current on the science shaping prevention and cure in #PxWire: buff.ly/tC66sCu
February 2, 2026 at 3:32 PM
The latest issue of #PxWire showcases how access to #LEN for #HIV PrEP is accelerating—and why its delivery is moving faster than any #PrEP product before it. buff.ly/tC66sCu
February 2, 2026 at 3:32 PM
The #PEPFAR stopwork order resulted in major declines in #PrEPAccess. Our latest issue of #PxWire shows the impact, country by country, with significant declines to life-saving #PrEP. #DeadlyPause buff.ly/tC66sCu
February 2, 2026 at 3:32 PM
The latest #PxWire tracks where oral #PrEP access stands after the #ForeignAid Freeze. From an accelerated process for delivering #LEN for #PrEP to new vaccine trials for #HIVPrevention, this issue tracks and translates the HIV prevention pipeline from research to rollout. buff.ly/tC66sCu
February 2, 2026 at 3:32 PM
Generic #lenacapavir (LEN) for #PrEP could become available in 2027 in up to 120 countries. Track the rollout of long-acting #HIVPrEP at www.prepwatch.org/long-acting-...

#PxWire #HIVprevention
October 23, 2025 at 1:56 PM
16 countries are rolling out CAB for #PrEP. Get all the details at avac.org/pxwire/.

#HIVprevention #HIV
October 23, 2025 at 1:53 PM
Our new #PxWire issue is out! It tracks funders & countries rolling out new #PrEP products; compares their prices; and shows sites launching the 1xmonth pill.

Read it all here: avac.org/pxwire/

@eltonjohnaidsfoundation.org @ciffchild.bsky.social @gatesfoundation.bsky.social @unitaid.bsky.social
October 23, 2025 at 1:50 PM
❗NEW ISSUE OF PXWIRE❗
FDA approval of injectable #lenacapavir for #PrEP brings promise, but US cuts to #HIV prevention & research threaten progress. This issue unpacks the KP program shutdowns, LEN’s market potential, and why investment in innovation must continue.

Read: avac.org/resource/pxw...
PxWire Volume 15, Issue 3
With the recent FDA approval of injectable lenacapavir (LEN) for PrEP and the drastic withdrawal of US investment in HIV prevention, the field must reimagine and recommit to getting PrEP rollout right...
avac.org
July 2, 2025 at 2:12 PM
The latest issue of #PxWire is here. As #PrEP programs are dismantled & #LEN for PrEP is poised to transform prevention, two forces are colliding in real time. Read about all of this, avac.org/resource/rep....
May 6, 2025 at 1:06 PM
‼️ Special edition of PxWire: We dive into the new US Administration’s assault on global health and its devastating impact on #HIV prevention—from crippling existing #PrEP delivery to threatening the rollout of #lenacapavir for PrEP and paralyzing R&D.

Read the full issue, avac.org/resource/pxw...
March 6, 2025 at 9:49 PM